Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs
- PMID: 20128446
Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs
Abstract
Implementation of HIV testing has the objective to increase screening, identify and counsel persons with infection, link them to clinical services and reduce transmission. Rapid tests and/or alternative biological samples (like oral fluid) give the option for a better general consent in approaching screening, immediate referral of HIV positives to medical treatment and partner notification. We tested the performance characteristics of an oral fluid-based rapid HIV test (Rapidtest HIV lateral flow-Healthchem diag. LLC) in comparison with routinely utilized methods in a selected population of known positive (N = 121) or negative (N = 754) subjects. The sensitivity of the rapid test was 99.1% (one false negative sample) and the specificity 98.8%. Five negatives showed a faint reactivity, 3 of these were reactive also in the reference test, one with a p24 only reaction in Western blot. If these 3 samples were excluded from the analysis the specificity increases to 99.2%. Results from our study confirm that, although a continuous improvement of the test performance is still needed to minimize false negative and positive results, rapid test and alternative biological samples may contribute to HIV prevention strategies by reaching a larger population particularly when and where regular screening procedures are difficult to obtain.
Similar articles
-
Evaluation of Calypte AWARE HIV-1/2 OMT antibody test as a screening test in an Indian setting.Indian J Med Microbiol. 2010 Oct-Dec;28(4):295-8. doi: 10.4103/0255-0857.71809. Indian J Med Microbiol. 2010. PMID: 20966557
-
Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.AIDS. 2006 Aug 1;20(12):1661-6. doi: 10.1097/01.aids.0000238413.13442.ed. AIDS. 2006. PMID: 16868448
-
Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies.AIDS. 2006 Aug 1;20(12):1655-60. doi: 10.1097/01.aids.0000238412.75324.82. AIDS. 2006. PMID: 16868447
-
The INSTI HIV-1/HIV-2 antibody test: a review.Expert Opin Med Diagn. 2013 May;7(3):299-308. doi: 10.1517/17530059.2013.774370. Epub 2013 Feb 25. Expert Opin Med Diagn. 2013. PMID: 23480561 Review.
-
Care of Patients With HIV Infection: Diagnosis and Monitoring.FP Essent. 2016 Apr;443:11-5. FP Essent. 2016. PMID: 27092562 Review.
Cited by
-
A Determination of Salivary and Serum Glucose Levels in Patients With Type II Diabetes Mellitus.Cureus. 2024 Feb 18;16(2):e54395. doi: 10.7759/cureus.54395. eCollection 2024 Feb. Cureus. 2024. PMID: 38505447 Free PMC article.
-
Saliva as a diagnostic fluid.Dent Clin North Am. 2011 Jan;55(1):159-78. doi: 10.1016/j.cden.2010.08.004. Dent Clin North Am. 2011. PMID: 21094724 Free PMC article. Review.
-
False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts.HIV Clin Trials. 2018 Feb;19(1):15-22. doi: 10.1080/15284336.2018.1429846. Epub 2018 Jan 31. HIV Clin Trials. 2018. PMID: 29384717 Free PMC article.
-
Enzyme-linked immunosorbent assay using recombinant SAG1 antigen to detect Toxoplasma gondii-specific immunoglobulin G antibodies in human sera and saliva.Clin Vaccine Immunol. 2013 Apr;20(4):468-73. doi: 10.1128/CVI.00512-12. Epub 2013 Jan 23. Clin Vaccine Immunol. 2013. PMID: 23345586 Free PMC article.
-
Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings.Bull World Health Organ. 2012 Dec 1;90(12):914-20. doi: 10.2471/BLT.12.102780. Epub 2012 Oct 19. Bull World Health Organ. 2012. PMID: 23284197 Free PMC article.